MIRXES HANG SENG IPO: WHAT IT MEANS FOR SINGAPORE STOCK MARKETS?
Dear readers, Singapore Biotech Startup Mirxes launched its initial public offering (IPO) in Hong Kong on Thursday 15 May 25. Based on Mirxes’ website, the company is a Singapore-headquartered micro ribonucleic acid (miRNA) technology company that is making diagnostic solutions for the screening of diseases accessible across our key markets in Asia, including Singapore and
MIRXES HANG SENG IPO: WHAT IT MEANS FOR SINGAPORE STOCK MARKETS? Read More »









